Abstract Body

Background: The role of regulatory T cells (Tregs) in vaccination has been poorly investigated. We have reported that vaccination with ex vivo-generated dendritic-cells (DC) loaded with HIV-lipopeptides (LIPO-5-DC vaccine) in HIV-infected patients was well tolerated and highly immunogenic. However, patients responded differently to vaccination. Here we hypothesized that the presence and/or induction of HIV-specific Tregs might explain this observation.

Methods: Fourteen HIV-1 infected individuals under effective antiretroviral therapy have been included in this study. Patients received LIPO-5-DC vaccine every 4 weeks during 16 weeks period. Blood was drawn prior (week -4) and after (week 16) vaccination. This was followed by analytical treatment interruption (ATI) at week 24 to measure the magnitude of viral rebound. To assess the antigen-specific effectors (Teffs) and Tregs responses, a novel assay was used in which coexpression of CD25 and CD134 reveals these cells after stimulation in vitro. CD39 and FoxP3 markers were used to delineate antigen-specific Tregs and distinguish them from effector specific- responses.

Results: Median LIPO-5-specific CD25+CD134+ polyfunctional T cells increased from 0.1% (IQR 0-0.3) before vaccination (week -4) to 2.1% (IQR 1.1-3.9) at week 16 following 4 immunizations (P=0.001) and were inversely correlated with viral replication following ATI (r=-0.71, p=0.006). The frequency of LIPO-5-specific Tregs prior to vaccination was elevated, accounting for a median 69.3% (IQR 55.8-75.2) of LIPO-5-specific response. After vaccination, the frequency of HIV-specific Tregs decreased (from 69.3 at week -4 to 31.7% at week 16) and inversely correlated with the HIV-specific IFNγ-producing cells (r=-0.64, P=0.002). These Tregs are highly suppressive as their depletion prior to stimulation led to a further increase in IFNγ responses. Vaccinees who displayed lower levels of LIPO-5-specific CD4+CD134+CD25+CD39+FoxP3+ Tregs responded better to the vaccine as indicated by a negative correlation between LIPO-5-specific Tregs and post-vaccination immune score.

Conclusions: We show that DC-vaccine skewed the HIV-specific response from regulatory to effector phenotype. Patients with lower magnitude of viral replication following ATI presented lower levels of HIV-specific Tregs. This underlies the role these cells play in HIV-infection and the necessity to take them into account for future vaccine trials.